Voetterl and colleagues examined the application of ‘Brainmarker-I’, an age- and sex-normalized electroencephalogram measure of individual alpha peak frequency, on predicting remission to therapeutic noninvasive neuromodulation protocols (repetitive transcranial magnetic stimulation and electroconvulsive therapy).
- Helena T. S. Voetterl
- Alexander T. Sack
- Martijn Arns
